• Something wrong with this record ?

Autophagy in MCF-7 cancer cells induced by copper complexes

K. Koňariková, GA. Perdikaris, H. Gbelcová, L. Andrezálová, M. Švéda, T. Ruml, L. Laubertová, S. Režnáková, I. Žitňanová,

. 2016 ; 68 (6) : 1221-1224. [pub] 20160730

Language English Country Poland

Document type Journal Article

BACKGROUND: Autophagy plays an important role in cancer cells. Targeting autophagy in cancer can provide new opportunities for drug development. METHODS: In this study we tested four Schiff base Cu(II) complexes against human breast cancer cells (MCF-7) and human non-cancerous cells (HEK-293T). We have tested their cytotoxic effect by evaluating IC50 using MTT test. To detect morphological changes of the actin fibers we have used fluorescent microscopy. To determine the type of cell death we used electrophoretic analysis and western blot analysis (protein LC3). RESULTS: IC50 values of the complexes increased with time of their influence, indicating acquired resistance of MCF-7 to the complexes. Healthy cells HEK-293T were not sensitive to the Cu(II) complexes. Compared with the control cells (cells without Cu(II) complexes) which were without morphological changes of actin fibers, Cu(II) complexes induced condensation and asymmetric conformational changes in actin filaments. To examine the type of cell death induced by the Cu(II) complexes we treated MCF-7 cells with Cu(II) complexes (1, 10, 50 and 100μmol/L) during a 72h incubation period. By electrophoresis we have not detected any DNA fragmentation. To determine whether Cu(II) complexes induced autophagy or necrotic cell death we used the western blot analysis. MCF-7 cells influenced with tested Cu(II) complexes produced LC3 protein after their 72h incubation indicating autophagy in MCF-7 cancer cells. CONCLUSIONS: Tested Schiff base copper (II) complexes have antiproliferative activity against cancer cells but not against healthy cells. They have induced autophagy in the cancer cell line MCF-7.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013508
003      
CZ-PrNML
005      
20170426094451.0
007      
ta
008      
170413s2016 pl f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.pharep.2016.07.011 $2 doi
035    __
$a (PubMed)27665074
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Koňariková, Katarína $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
245    10
$a Autophagy in MCF-7 cancer cells induced by copper complexes / $c K. Koňariková, GA. Perdikaris, H. Gbelcová, L. Andrezálová, M. Švéda, T. Ruml, L. Laubertová, S. Režnáková, I. Žitňanová,
520    9_
$a BACKGROUND: Autophagy plays an important role in cancer cells. Targeting autophagy in cancer can provide new opportunities for drug development. METHODS: In this study we tested four Schiff base Cu(II) complexes against human breast cancer cells (MCF-7) and human non-cancerous cells (HEK-293T). We have tested their cytotoxic effect by evaluating IC50 using MTT test. To detect morphological changes of the actin fibers we have used fluorescent microscopy. To determine the type of cell death we used electrophoretic analysis and western blot analysis (protein LC3). RESULTS: IC50 values of the complexes increased with time of their influence, indicating acquired resistance of MCF-7 to the complexes. Healthy cells HEK-293T were not sensitive to the Cu(II) complexes. Compared with the control cells (cells without Cu(II) complexes) which were without morphological changes of actin fibers, Cu(II) complexes induced condensation and asymmetric conformational changes in actin filaments. To examine the type of cell death induced by the Cu(II) complexes we treated MCF-7 cells with Cu(II) complexes (1, 10, 50 and 100μmol/L) during a 72h incubation period. By electrophoresis we have not detected any DNA fragmentation. To determine whether Cu(II) complexes induced autophagy or necrotic cell death we used the western blot analysis. MCF-7 cells influenced with tested Cu(II) complexes produced LC3 protein after their 72h incubation indicating autophagy in MCF-7 cancer cells. CONCLUSIONS: Tested Schiff base copper (II) complexes have antiproliferative activity against cancer cells but not against healthy cells. They have induced autophagy in the cancer cell line MCF-7.
650    _2
$a zvířata $7 D000818
650    _2
$a autofagie $x účinky léků $x fyziologie $7 D001343
650    _2
$a proliferace buněk $x účinky léků $x fyziologie $7 D049109
650    _2
$a měď $x farmakologie $x toxicita $7 D003300
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a myši $7 D051379
650    _2
$a Schiffovy báze $x farmakologie $x toxicita $7 D012545
655    _2
$a časopisecké články $7 D016428
700    1_
$a Perdikaris, Georgios A $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Gbelcová, Helena $u Institute of Medical Biology and Genetics, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Andrezálová, Lucia $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic. $7 gn_A_00006628
700    1_
$a Švéda, Martin $u Institute of Chemical Technology, Department of Biochemistry and Microbiology, Faculty of Food Biochemical Technology, Technicka 5, 166 28, Prague, Czech Republic.
700    1_
$a Ruml, Tomáš $u Institute of Chemical Technology, Department of Biochemistry and Microbiology, Faculty of Food Biochemical Technology, Technicka 5, 166 28, Prague, Czech Republic.
700    1_
$a Laubertová, Lucia $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Režnáková, Soňa $u Institute of Medical Biology and Genetics, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic.
700    1_
$a Žitňanová, Ingrid $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic. Electronic address: ingrid.zitnanova@fmed.uniba.sk.
773    0_
$w MED00165879 $t Pharmacological reports PR $x 1734-1140 $g Roč. 68, č. 6 (2016), s. 1221-1224
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27665074 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170426094809 $b ABA008
999    __
$a ok $b bmc $g 1199973 $s 974286
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 68 $c 6 $d 1221-1224 $e 20160730 $i 1734-1140 $m Pharmacol. Reports $n Pharmacol. Rep. $x MED00165879
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...